Reckitt Benckiser discontinues sale of Suboxone heroin tablets in the US

September 28, 2012

Reckitt Benckiser Pharmaceuticals has voluntarily discontinued the sale of Suboxone tablets, a replacement for heroin dependency, after a report suggested the tablets were more likely to be accidently taken by young children. (Source: Pharmaceutical Technology)

Read the full article →

SUBOXONE (Buprenorphine Hydrochloride And Naloxone Hydrochloride) Tablet [Bryant Ranch Prepack]

September 28, 2012

Updated Date: Sep 26, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Read the full article →

Reckitt Benckiser Pharmaceuticals Inc. to Voluntarily Discontinue the Supply of Suboxone Tablets (buprenorphine and naloxone sublingual tablets [CIII])

September 28, 2012

September 25, 2012 — Reckitt Benckiser Pharmaceuticals Inc. confirms that it notified the U.S. Food and Drug Administration (FDA) on September 18, 2012 that the company is voluntarily discontinuing the supply of Suboxone Tablets in the US… (Source: Drugs.com – Pharma News) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm […]

Read the full article →

CADTH: Review of opioid dependence treatment guidelines

September 27, 2012

Source: Canadian Agency for Drugs and Technologies in Health (CADTH) Area: News This rapid review by the Canadian Agency for Drugs and Technologies in Health (CADTH) reviews recommendations on the treatment in patients (including pregnant women) with opioid dependence from evidence-based guidelines, with a special interest in the recommendations for treatment of opioid dependence in […]

Read the full article →

CADTH: Review of opioid dependence treatment guidelines

September 27, 2012

Source: Canadian Agency for Drugs and Technologies in Health (CADTH) Area: News This rapid review by the Canadian Agency for Drugs and Technologies in Health (CADTH) reviews recommendations on the treatment in patients (including pregnant women) with opioid dependence from evidence-based guidelines, with a special interest in the recommendations for treatment of opioid dependence in […]

Read the full article →

CADTH: Review of opioid dependence treatment guidelines

September 27, 2012

Source: Canadian Agency for Drugs and Technologies in Health (CADTH) Area: News This rapid review by the Canadian Agency for Drugs and Technologies in Health (CADTH) reviews recommendations on the treatment in patients (including pregnant women) with opioid dependence from evidence-based guidelines, with a special interest in the recommendations for treatment of opioid dependence in […]

Read the full article →

CADTH: Review of opioid dependence treatment guidelines

September 27, 2012

Source: Canadian Agency for Drugs and Technologies in Health (CADTH) Area: News This rapid review by the Canadian Agency for Drugs and Technologies in Health (CADTH) reviews recommendations on the treatment in patients (including pregnant women) with opioid dependence from evidence-based guidelines, with a special interest in the recommendations for treatment of opioid dependence in […]

Read the full article →

Reckitt to discontinue Suboxone tablets in U.S.

September 27, 2012

LONDON (Reuters) – British consumer goods group Reckitt Benckiser is to withdraw its Suboxone heroin treatment tablets in favor of a film version in the United States over the next six months due to the higher risk of children getting hold of the tablets. (Source: Reuters: Health)

Read the full article →

Reckitt to discontinue Suboxone tablets in U.S.

September 27, 2012

LONDON (Reuters) – British consumer goods group Reckitt Benckiser is to withdraw its Suboxone heroin treatment tablets in favor of a film version in the United States over the next six months due to the higher risk of children getting hold of the tablets. (Source: Reuters: Health)

Read the full article →

Reckitt to discontinue Suboxone tablets in U.S.

September 27, 2012

LONDON (Reuters) – British consumer goods group Reckitt Benckiser is to withdraw its Suboxone heroin treatment tablets in favor of a film version in the United States over the next six months due to the higher risk of children getting hold of the tablets. (Source: Reuters: Health)

Read the full article →

← Previous Entries

Next Entries →